Navigation Links
Lightning Brewery’s Craft Beer Old Tempestuous Ale Wins Best of Show at 2012 California State Fair Commercial Brewing Competition
Date:6/22/2012

San Diego, California (PRWEB) June 22, 2012

San Diego’s Lightning Brewery announced today that its craft beer Old Tempestuous Ale won Best of Show at the California State Fair Commercial Brewing Competition, beating 475 other entries from 60 state breweries including Karl Strauss, Island Brewing and Pyramid. Best of Show is the fair’s highest award for commercial craft beer.

Dr. James Crute, Lightning Brewery’s owner, was thrilled to receive the honor. He explains, “We find that Old Tempestestuous Ale is enjoyed most for its rich and complex maltyness. Like many of our craft beers, we do all we can to recreate classic beer styles in a modern brewery. For Old Tempest Ale, we made sure to source a specialized UK ale-type yeast, Golding hops imported from the East Kent region of the UK, and imported malt from the Simpsons Malt of England, the last free-standing floor malster in the UK.”

In addition to the coveted Best of Show prize, Lightning Brewery won medals for eight more of its craft beer entries: golds for Lightning Amber Ale, Thunderweizen, Old Tempestuous Ale and Electrostatic Ale. It also won a silver medal for its Fair Weather Pale Ale and bronze medals for its Elemental Pilsner, Sauerstom Ale and Blac
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. A new imaging system produces 3-D models of monuments using unmanned aircraft
2. Synteract and MediciNova Partner in "Fight For Air Walk" to Support the American Lung Association in California
3. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
4. Epitomics, Inc. and University of California, Davis, Complete Star Program for High-Throughput Measurement of Antibody-Antigen Interactions
5. Agendia Signs Contract with Blue Shield of California
6. Intellect Neurosciences Enters Collaboration Agreement with Leading Alzheimers Research Group at University of California Irvine to Test First in Class Dual Target Vaccine
7. Synthetic Genomics Inc. Purchases 81 Acre Site in South California Desert for Scale up and Testing of Innovative Algae Strains
8. Pacific BioStorage Announces an Exciting New First for The Life Sciences Industry in Southern California
9. Arizona State University engineers aim to improve performance of technology in extreme environments
10. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
11. Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lightning Brewery’s Craft Beer Old Tempestuous Ale Wins Best of Show at 2012 California State Fair Commercial Brewing Competition
(Date:8/20/2014)... analysis of patented university inventions licensed to biotechnology ... to commercialization. To open these roadblocks, the researchers ... during the discovery stage could lead to faster ... frequently derived from discoveries made in university laboratories ... known during clinical trials, which have a high ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 High ... and apply the most complete climate and Earth ... demanding climate change issues. , Eight national laboratories, ... with the National Center for Atmospheric Research, four ... new effort. Other participating national laboratories include Argonne, ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Not long ... E&L studies should be performed late in the development ... known. But current regulatory trends suggest that, like many ... the rise. In recent years, multiple drug sponsors have ... or address specific questions during phase I/II. It’s not ...
(Date:8/20/2014)... Sofia, Bulgaria (PRWEB) August 20, 2014 ... was released today including improvements to the ... rates and connectors for Lucene, SOLR and Elasticsearch. ... change for this high performance triplestore – GraphDB™ ... organizations interested in deploying the only mature enterprise ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4
... - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI , ... second quarter ended June 30, 2009. , "We were ... Medical Products business during the quarter, including continued acceleration ... said Dr. William Hunter, President and CEO of Angiotech. ...
... , , SEATTLE, Aug. ... reported recent achievements and financial results for the second quarter and ... "The second quarter of 2009 was a transforming quarter for the ... III data at the American Society of Clinical Oncology Annual Meeting ...
... , NEW YORK, Aug. 5 ... biopharmaceutical company focused on the acquisition, development and commercialization ... of life-threatening diseases, including renal disease and cancer (the ... ended June 30, 2009. , , ...
Cached Biology Technology:Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 2Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 3Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 4Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 5Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 6Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 7Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 8Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 9Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 10Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 11Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 12Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 13Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 14Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 15Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 16Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 17Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 18Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 19Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 20Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 21Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 22Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 23Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 24Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 25Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 26Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 27Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009 28Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 2Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 3Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 4Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 5Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 6Cell Therapeutics Second Quarter Net Loss Decreases 54%; Pixantrone NDA Submitted to the FDA for Approval 7Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results 3
(Date:8/20/2014)... approximately 3 million infants, a team of scientists across ... Massachusetts Medical School, have shown that newborn screening for ... public health newborn screening programs. Data from 11 newborn ... the Journal of the American Medical Association ... newborns is higher than previously thought and believed to ...
(Date:8/20/2014)... have suffered concussions ready to return to action? A ... school athletes who head back on the field with ... in their abilities to simultaneously walk and do simple ... in their balance and/or altered walking speed, was found ... had returned to activity in less than a month. ...
(Date:8/20/2014)... could one day be made out of cocoa, rice ... reporting. The novel process they developed and their results, ... and plastic waste problems, appear in the ACS journal ... and colleagues at the Italian Institute of Technology point ... its production reached 288 million tons worldwide, but its ...
Breaking Biology News(10 mins):Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3
... the health of the world,s oceans down a rapid ... or perhaps ultimately reverse the catastrophic problems they are ... a professor of oceanography at Scripps Institution of Oceanography ... of the oceans and their ecological health. Publishing his ...
... A critical component of NASA,s Mars exploration program ... in-depth analysis, plans for which are detailed in ... peer-reviewed journal published by Mary Ann Liebert, Inc. ... www.liebertpub.com/ast In the published report entitled, ...
... newly developed robot capable of diving as deep ... has been successfully completed by scientists and engineers ... the University of Washington (UW). The vehicle ... for seafloor instruments that will be deployed in ...
Cached Biology News:Oceans on the precipice: Scripps scientist warns of mass extinctions and 'rise of slime' 2Oceans on the precipice: Scripps scientist warns of mass extinctions and 'rise of slime' 3Bringing Martian samples to Earth -- preparations outlined in journal Astrobiology 2Robot vehicle surveys deep sea off Pacific Northwest 2Robot vehicle surveys deep sea off Pacific Northwest 3
Mouse monoclonal [YPF19] to Yersinia pestis ( Abpromise for all tested applications)....
... extracts cytosolic proteins from mammalian ... their phosphorylation state. The reagent, ... Protein Extraction reagent, includes four ... with Western blotting, immunoprecipitations, and ...
... The features we add to WinList ... the product every day. Features like automatic ... are the result of good suggestions, thoughtful ... of the features you depend on are ...
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: